175 related articles for article (PubMed ID: 18421461)
1. Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers.
Mathers MJ; Zumbe J; Wyler S; Roth S; Gerken M; Hofstädter F; Klotz T
World J Urol; 2008 Jun; 26(3):251-6. PubMed ID: 18421461
[TBL] [Abstract][Full Text] [Related]
2. Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
Cancer Res Treat; 2017 Jul; 49(3):607-615. PubMed ID: 27658388
[TBL] [Abstract][Full Text] [Related]
3. History of urological malignancies before kidney transplantation, oncological outcome on the long term.
Boissier R; Hidalgo R; Rodríguez Faba O; Territo A; Subiela JD; Huguet J; Sánchez-Puy A; Gallioli A; Vanacore D; Mercade A; Martinez C; Palou J; Guirado L; Breda A
Actas Urol Esp (Engl Ed); 2021 Dec; 45(10):623-634. PubMed ID: 34764048
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune disease and subsequent urological cancer.
Liu X; Ji J; Forsti A; Sundquist K; Sundquist J; Hemminki K
J Urol; 2013 Jun; 189(6):2262-8. PubMed ID: 23228387
[TBL] [Abstract][Full Text] [Related]
5. [Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma].
Klotz T; Hofstädter F; Gerken M
Urologe A; 2003 Nov; 42(11):1485-90. PubMed ID: 14624348
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
8. Incidence of urological cancers in neurological patients: a review of the literature from the EAU Young Academic Urologist Functional Group.
Cancrini F; Osman N; Doizi S; Guillot-Tantay C; Hüsch T; Illiano E; Tutolo M; Tienza A; Culha MG; Vale L; Raison N; Herve F; Grande P; Roupret M; Phé V
Minerva Urol Nephrol; 2023 Apr; 75(2):163-171. PubMed ID: 36999836
[TBL] [Abstract][Full Text] [Related]
9. [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
Ouedraogo S; Traore MT; Kambire JL; Ouedraogo S; Bere B; Kabore AF
Bull Cancer; 2019 Oct; 106(10):868-874. PubMed ID: 31350015
[TBL] [Abstract][Full Text] [Related]
10. [Urological follow-up and development of cancer after renal transplantation].
Giessing M
Urologe A; 2015 Oct; 54(10):1393-401. PubMed ID: 26459582
[TBL] [Abstract][Full Text] [Related]
11. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
12. [Increase in uro-oncological health care needs due to demographic change: Extrapolation of cancer incidence numbers through 2030 as a basis for directed regional planning].
Winter A; Vohmann C; Wawroschek F; Kieschke J
Urologe A; 2015 Sep; 54(9):1261-8. PubMed ID: 25490922
[TBL] [Abstract][Full Text] [Related]
13. Management of Urological Malignancy in Heart and Lung Transplant Recipients: An Irish National Cohort Study.
Keenan RA; Haroon U; Ryan P; Harrington B; Jones A; Aboelmagd M; Connolly S; O'Mally KJ; Galvin D; Hegarty N
Exp Clin Transplant; 2021 Oct; 19(10):1069-1075. PubMed ID: 34641776
[TBL] [Abstract][Full Text] [Related]
14. Gout patients have an increased risk of developing most cancers, especially urological cancers.
Chen CJ; Yen JH; Chang SJ
Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
[TBL] [Abstract][Full Text] [Related]
15. A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?
Kurpad R; Kim W; Rathmell WK; Godley P; Whang Y; Fielding J; Smith L; Pettiford A; Schultz H; Nielsen M; Wallen EM; Pruthi RS
Urol Oncol; 2011; 29(4):378-82. PubMed ID: 19576797
[TBL] [Abstract][Full Text] [Related]
16. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Li H; Zhu C; Wu J; Ma Y; Jin X; Wei X; Wang K; Li H
Int Urol Nephrol; 2021 Mar; 53(3):471-477. PubMed ID: 33052518
[TBL] [Abstract][Full Text] [Related]
17. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
Saito K; Kihara K
Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
[TBL] [Abstract][Full Text] [Related]
18. Urologic cancer in Thailand.
Lojanapiwat B
Jpn J Clin Oncol; 2015 Nov; 45(11):1007-15. PubMed ID: 26355159
[TBL] [Abstract][Full Text] [Related]
19. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]